AdvanDx Lands $8,000,000 Series C Financing

  • Feed Type
  • Date
    8/18/2009
  • Company Name
    AdvanDx
  • Mailing Address
    10A Roessler Road Woburn, MA 01801
  • Company Description
    AdvanDx develops and markets molecular-based, in vitro diagnostic tests that aid in the diagnosis and prevention of infectious diseases. The rapid test results are available in hours instead of days and allow healthcare providers to make more informed therapy decisions early and improve both the quality of patient care and overall hospital operations.
  • Website
    http://www.advandx.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $8,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The funding will be used to fund the expansion of AdvanDx’s molecular diagnostics product offering as well as its international sales and marketing activities.
  • M&A Terms
  • Venture Investor
    SLS Ventures
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.